HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who are living with HIV and currently taking antiretroviral therapy (HIV medications)
- People whose HIV viral load (the amount of virus in the blood) has been below 20 copies/mL at two separate tests over at least 6 months, and whose doctor is planning to switch them to a different medication regimen
- People who meet the age requirement but are not planned for a medication switch may be eligible for the control group, including those with low-level viremia — meaning two or more consecutive blood tests showing a viral load between 21 and 200 copies/mL in the past two years (confirm with trial site)
Who may not be able to join:
- People who are currently pregnant
- People whose HIV treatment is not working (known as virologic failure), meaning the virus is not being adequately controlled by their current medications
- People who are currently experiencing an opportunistic infection (a serious infection that occurs when the immune system is weakened)
- People who are currently incarcerated (in prison)
- People who are not able to give their own informed consent to participate
- People who have a mental illness (confirm with trial site regarding specific conditions affected)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shui Shan Lee, MD, S.H. Ho Research Centre for Infectious Diseases, The Chinese University of Hong kong
Phone: +852 22528812
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportional difference of drug resistance mutation at short term after regimen switch; Proportional difference of drug resistance mutation at long term after regimen switch
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.